Eprosartan RC A:
(E)-3-(2-Butyl-1H-imidazol-5-yl)-2-(thiophen-2-yl-methyl)acrylic acid ; C15H18N2O2S ; MW: 290.38 ; |
Eprosartan:
(E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienyl methyl)-2-propenoic acid ; CAS : 133040-01-4 ; C23H24N2O4S ; MW: 424.51 ; |
Eprosartan RC B :
3-(Thiophen-2-yl)propanoic acid ; CAS : 5928-51-8 ; C7H8O2S ; MW: 156.20 ; |
Eprosartan RC C:
2-(Thiophen-2-ylmethyl)malonic acid ; CAS : 4475-24-5 ; C8H8O4S ; MW: 200.21 ; |
Eprosartan RC D:
4-(Bromomethyl)benzoic acid ; CAS : 6232-88-8 ; C8H7BrO2 ; Mol. Wt.: 215.04 ; |
Eprosartan RC E:
4-(Hydroxymethyl)benzoic acid ; CAS : 3006-96-0 ; C8H8O3 ; MW: 152.15 ; |
Eprosartan RC F:
(Z)-4-({2-Butyl-5-[2-carboxy-3-(thiophen-2-yl)prop-1-enyl]-1H-imidazol-1-yl}methyl)benzoic acid ; CAS : 148674-39-9 ; C23H24N2O4S ; Mol. Wt.: 424.51 ; |